Gilead Sciences Inc Stock
Gilead Sciences Inc Stock
The Gilead Sciences Inc stock is trending slightly upwards today, with an increase of €0.16 (0.260%) compared to yesterday's price.
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 84 € shows a positive potential of 35.16% compared to the current price of 62.15 € for Gilead Sciences Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Gilead Sciences Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Gilead Sciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Gilead Sciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | 0.260% | -0.848% | -1.085% | -15.059% | -15.222% | 9.853% | 4.185% |
| Exact Sciences | -0.590% | -1.242% | -13.859% | -35.970% | -28.075% | -43.475% | -43.410% |
| Incyte Corp. | 0.230% | 0.265% | 6.570% | -10.129% | -6.803% | -22.121% | -23.251% |
| Regeneron Pharmaceuticals Inc. | 0.020% | 0.593% | 8.868% | 30.363% | 14.834% | 120.197% | 229.069% |
Comments
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at Maxim Group from $90.00 to $85.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for GILD provided by MarketBeat
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target lowered by analysts at TD Cowen from $90.00 to $85.00. They now have a "buy" rating on the stock.
Show more
Ratings data for GILD provided by MarketBeat